Breaking News

Bird flu is spreading. Could cow vaccines be the answer?

August 5, 2024

Hey. Alexa from STAT+ Today here. Sharing that this week, you can get the first three months of STAT+ for $20. This includes unlimited access to our reporting, unlocking exclusive newsletters, and more. Seriously, it's a good deal.

Okay, that's enough from me now. Thank you for reading our reporting and being here today.

Use of incentives, known as contingency management, is one of the few proven ways to reduce methamphetamine use.
PATRICK T. FALLON/AFP via Getty Images

Politics is holding back the best tool for treating meth addiction

Offering people incentives to stop using meth, a practice known as contingency management, runs against a federal cap of $75 per year.

By Lev Facher


The infectious disease doctor shortage will hit marginalized people the hardest

Half of all infectious disease residencies now go unfilled. One of the lowest-compensated medical specialties needs new government incentives, experts say.

By Alia Sajani


FDA ad comm favors Zevra's Niemann-Pick drug

Today's biotech news updates include the dangers of off-brand GLP-1s, a foiled plan to privatize 23andMe, and Zevra's Niemann-Pick drug.

By Meghana Keshavan



Adobe

STAT+ | Medicare scrambles to keep prescription drug plan premiums stable ahead of elections

Federal officials are working to keep Medicare prescription drug plan premiums from jumping ahead of the election.

By John Wilkerson


Opinion: Performance-enhancing drugs or placebos? The myth at the heart of anti-doping

Research shows that some performance-enhancing drugs don't improve athletes' performance, while placebos can do that.

By Jo Morrison and Eric Moore


Morning Rounds: The 'very risky business' of buying weight loss drugs online

Today's health news roundup includes mpox, the risks of buying weight loss drugs without a prescription, and a tool to treat meth addiction.

By Theresa Gaffney


Adobe

Opinion: Phasing out the 'D-word'

The term dementia is an outdated, inaccurate, and stigmatizing term that should be permanently retired.

By Mike Zuendel


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments